Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
about
Monocyte and interferon based therapy for the treatment of ovarian cancer.Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer.Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer.Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer.New Approaches for Immune Directed Treatment for Ovarian Cancer.Anti-angiogenic agents in ovarian cancer: past, present, and future.Specific immunotherapy in ovarian cancer: a systematic review.Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer.Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo.Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer.Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.
P2860
Q35973378-1977C7C6-C8F7-4401-AC9C-6B17A44E08ACQ37442989-721F7F1F-6336-4A1F-9B5A-D3A939A50E86Q37616503-8C1307FF-4F91-45BA-84E3-2FCB1E5C2B0EQ37620476-F7B606F5-64AD-4472-B305-40E9CEE38F81Q37687582-D5F44CF1-1B05-43AB-8278-2A5FB04291B6Q38760516-BB100821-C509-4680-A236-CA8B86734E67Q38872239-2B2400C1-527C-4A7A-B61B-7EA3E64E5FCBQ38948893-D4EC5A27-1A9A-4916-AAB0-10D5856EB12DQ39402079-FC7EFBB3-0EDB-41F1-88AF-A5BF00ACA50BQ50544077-FAF06FA9-0D6E-4B79-AED7-3BB28B8C6158Q55282202-8BEB7148-DD14-44DA-9B33-942E84787ECFQ55316979-FF1749A6-91DC-4471-B8A2-F70E3543A148
P2860
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@ast
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@en
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@nl
type
label
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@ast
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@en
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@nl
prefLabel
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@ast
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@en
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@nl
P2860
P50
P356
P1476
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
@en
P2093
Francesca De Felice
Pierluigi Benedetti Panici
P2860
P304
P356
10.1155/2015/191832
P407
P5008
P577
2015-07-07T00:00:00Z